Sphingolipid therapy in myocardial ischemia–reperfusion injury
- 31 March 2008
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 1780 (3) , 571-576
- https://doi.org/10.1016/j.bbagen.2007.08.014
Abstract
No abstract availableKeywords
This publication has 77 references indexed in Scilit:
- The no-reflow phenomenon: A basic mechanism of myocardial ischemia and reperfusionBasic Research in Cardiology, 2006
- Heart Disease and Stroke Statistics—2006 UpdateCirculation, 2006
- Protein GlycationCirculation Research, 2004
- Sphingosine 1-Phosphate, a Key Cell Signaling MoleculeJournal of Biological Chemistry, 2002
- The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusionCardiovascular Research, 1996
- Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphateNature, 1996
- Role of oxidative stress in development of complications in diabetesDiabetes, 1991
- Role of Oxidative Stress in Development of Complications in DiabetesDiabetes, 1991
- Enzymatic synthesis of N,N-dimethyl-sphingosine: Demonstration of the sphingosine: N-methyltransferase in mouse brainBiochemical and Biophysical Research Communications, 1989
- Oxygen-Derived Free Radicals in Postischemic Tissue InjuryNew England Journal of Medicine, 1985